02666 UNI MEDICAL
- 5.120
- +0.070+1.39%
UNI MEDICAL News
Global Healthcare (02666.HK): The business structure is further optimized and the development trend is steady, moderate and positive
Global Healthcare (02666.HK): Comprehensive medical business profitability improvement, full-cycle management of equipment to achieve energy level leaps
Global Healthcare (02666.HK) 2023 Annual Report Review: Health-Driven Performance Financing Structure Improvements
Global Healthcare (02666.HK): A central enterprise industry group based on financial rent and medical success
Pacific Securities: First grant to Global Healthcare (02666) “increase in holdings” rating, complete acquisition, and new outlet
Global Healthcare (02666.HK): Combining industry and finance creates a new outlet for development and acquisition with a complete layout
Global Healthcare (02666.HK): Comprehensive Healthcare Business Profitability Improvement Acceleration and Equipment Full-cycle Management
Global Healthcare (2666.HK): Hospital business revenue in FY22 is expected to surpass financial business
General Global Healthcare (2666.HK): Financial business prospects are slightly weak; hospital business consolidation is progressing steadily
General Global Healthcare (2666.HK): First-half performance is expected to be pressured by the epidemic; the company's dividend ratio is attractive
Global Healthcare (2666.HK): Steady recovery in first quarter results
Global Healthcare (2666.HK): The impact of the epidemic has been gradually reduced
General Global Healthcare (2666.HK): Steady transformation of diversified medical service formats suggests refocusing
Global Healthcare (2666.HK): The first half of the year's performance exceeded expectations, and state-owned hospitals successfully merged
Global Healthcare (2666.HK): Current business is growing steadily, and hospital management has ushered in opportunities
Global Healthcare (02666.HK) Annual Report Review: Performance Meets Expectations New Business Has Been Long Term Downgraded to “Hold”
Global Healthcare (2666.HK): China's leading integrated healthcare service provider
Global Medical (02666.HK) Quarterly report comments: the third quarter financial data review results are in line with expectations and look forward to the landing of the new project.
Global Healthcare (02666.HK): Steady development of traditional businesses and hospital management ushered in opportunities
Global Healthcare (02666.HK): Undervaluation+Margin of Safety+Performance Flexibility Reiterates “Buying”
Analysis
Price Target
No Data
No Data